Trials / Terminated
TerminatedNCT03503097
Genetic Testing for Men With Metastatic Prostate Cancer
GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 799 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study provides genetic testing to men with prostate cancer that has spread to other parts of the body (metastatic prostate cancer) and will look for inherited genetic mutations in about 30 cancer-risk genes. The researchers seek to learn about the participant's opinions and concerns about genetic testing, to determine if this is an acceptable way to deliver testing and to potentially help guide the participant's treatment. Neither treatment nor any decisions related to treatment will take place on this study, but researchers will share each participant's genetic testing results with that participant.
Detailed description
OUTLINE: Participants receive web-based or hard-copy questionnaires and saliva collection kits via mail or in person. Participants also provide saliva samples to be mailed back to Color Genomics for genetic testing once complete. Participants then receive phone-based genetic counseling if they are identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene. All participants have access to phone-based genetic counseling whether or not they are not found to have a mutation. After study completion, participants are followed up at 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biospecimen Collection | Provide saliva samples |
| OTHER | Genetic Counseling | Undergo counseling |
| OTHER | Genetic Testing | Undergo genetic testing |
| OTHER | Laboratory Biomarker Analysis | Correlative studies |
| BEHAVIORAL | Questionnaire | Complete questionnaire |
Timeline
- Start date
- 2017-08-21
- Primary completion
- 2024-08-21
- Completion
- 2025-09-17
- First posted
- 2018-04-19
- Last updated
- 2025-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03503097. Inclusion in this directory is not an endorsement.